Boston Scientific admits stent risks

Sep 07, 2006

The U.S.-based Boston Scientific Corp. has admitted there is an increased risk of blood clots caused by use of its drug-coated cardiac stent.

The company -- the leading stent seller in the nation -- says an analysis of clinical data reveals the increased risk of blood clots months after a stent is implanted, The Wall Street Journal reported, noting the announcement marks the first time any stent maker has acknowledged the heightened risk of side effects from using drug-coated stents.

Stents are small, wire-mesh tubes that are inserted into a blood vessel or other body structure to provide support and keep the structure open. The drugs used to coat some stents are designed to prevent growth of tissue after implantation.

The Journal said stent sales exceed $5 billion annually in a market dominated by Boston Scientific and Johnson & Johnson.

Boston Scientific, which has its headquarters in Natick, Mass., claims recent studies suggest both its Taxus brand of stent and J&J's Cypher stent present similar risks of late-occurring blood clots. J&J company officials, however, told the Journal they see no statistically significant risk of late thrombosis caused by their Cypher stents.

Copyright 2006 by United Press International

Explore further: Tips offered to docs, spouses for maintaining happy marriage

add to favorites email to friend print save as pdf

Related Stories

Zinc: The perfect material for bioabsorbable stents?

Apr 30, 2013

(Phys.org) —In 2012, more than 3 million people had stents inserted in their coronary arteries. These tiny mesh tubes prop open blood vessels healing from procedures like a balloon angioplasty, which widens ...

Mussel goo inspires blood vessel glue

Dec 11, 2012

(Phys.org)—A University of British Columbia researcher has helped create a gel – based on the mussel's knack for clinging to rocks, piers and boat hulls – that can be painted onto the walls of blood vessels and stay ...

Studies question heart bypass, angioplasty method

Apr 04, 2011

(AP) -- Two new studies could change care for hundreds of thousands of heart patients each year. One finds that bypass surgery has been overrated for many people with very weak hearts from clogged arteries ...

'Cow valve' heart implant hailed as breakthrough

Apr 03, 2011

A new type of heart valve made with cow tissue and inserted by catheter was hailed on Sunday as a major breakthrough that could eliminate the need for open heart surgery in some patients, US doctors said Sunday.

Recommended for you

Evidence plays limited role in OTC decision making

8 hours ago

(HealthDay)—For pharmacy graduates and tutors, evidence seems to play a limited role in over-the-counter decision making, according to a study published online Dec. 11 in the Journal of Evaluation in Cl ...

Shared medical appointments beneficial in geriatric care

8 hours ago

(HealthDay)—For older patients, a shared medical appointment (SMA) program facilitates early detection and referral for geriatric syndromes, according to an article published online Nov. 29 in the Journal of ...

Restrictions lifted at British bird flu farm

13 hours ago

Britain on Sunday lifted all restrictions at a duck farm in northern England after last month's outbreak of H5N8 bird flu, the same strain seen in recent cases across Europe.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.